Short-term Dual Therapy or Mono Therapy With Acetaminophen and Ibuprofen for Fever: A Network Meta-Analysis

医学 布洛芬 对乙酰氨基酚 不利影响 置信区间 优势比 荟萃分析 随机对照试验 背景(考古学) 麻醉 内科学 药理学 古生物学 生物
作者
Juan E. De la Cruz-Mena,Areti-Angeliki Veroniki,Jorge Acosta‐Reyes,Andrés Felipe Estupiñán-Bohorquez,Jaime A. Ibarra,M Pana,Javier M. Sierra,Iván D. Flórez
出处
期刊:Pediatrics [American Academy of Pediatrics]
标识
DOI:10.1542/peds.2023-065390
摘要

CONTEXT: There is uncertainty whether acetaminophen and ibuprofen are similar in their effects and safety when used as single or dual (alternating or combined) therapies. OBJECTIVE: To assess the comparative efficacy of acetaminophen, ibuprofen alone, alternating, or combined through a systematic review and network meta-analysis. DATA SOURCES: Medline, Embase, and CENTRAL from inception to September 20, 2023. STUDY SELECTION: Randomized trials comparing acetaminophen, ibuprofen, both alternating, and both combined, for treating children with fever. DATA EXTRACTION: Two reviewers independently screened abstracts and full texts, extracted the data, and assessed the risk of bias. We performed pairwise and network meta-analysis using the random-effects model. RESULTS: We included 31 trials (5009 children). We found that combined (odds ratio [OR], 0.19; confidence interval [CI], 0.09–0.42) and alternating therapies (OR, 0.20; CI, 0.06–0.63) may be superior to acetaminophen, whereas ibuprofen at a high dose may be comparable (OR, 0.98; CI, 0.63–1.59) in terms of proportion of afebrile children at the fourth hour. These results were similar at the sixth hour. There were no differences between ibuprofen (low or high dose), or alternating, or combined with acetaminophen in terms of adverse events. LIMITATIONS: We only evaluated the efficacy and safety during the first 6 hours. CONCLUSIONS: Dual may be superior to single therapies for treating fever in children. Acetaminophen may be inferior to combined or alternating therapies to get children afebrile at 4 and 6 hours. Compared with ibuprofen, acetaminophen was also inferior to ibuprofen alone at 4 hours, but similar at 6 hours. PROSPERO registration: CRD42016035236.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Radon发布了新的文献求助10
1秒前
2秒前
共享精神应助花落水自流采纳,获得10
2秒前
3秒前
李思涵发布了新的文献求助10
3秒前
小金发布了新的文献求助30
8秒前
9秒前
上官若男应助Su采纳,获得10
10秒前
诚心爆米花完成签到,获得积分10
11秒前
逆境完成签到,获得积分10
12秒前
12秒前
DH完成签到 ,获得积分10
13秒前
15秒前
求求啦发布了新的文献求助10
15秒前
华贞完成签到,获得积分10
16秒前
科研通AI2S应助落后从阳采纳,获得30
16秒前
古凊完成签到 ,获得积分10
17秒前
小辛发布了新的文献求助10
17秒前
风趣友瑶发布了新的文献求助20
17秒前
18秒前
悦耳的柠檬完成签到,获得积分10
19秒前
Singularity应助PH采纳,获得10
20秒前
xie老板发布了新的文献求助10
20秒前
21秒前
22秒前
23秒前
24秒前
犯困小黄人完成签到,获得积分10
24秒前
Su发布了新的文献求助10
26秒前
liu发布了新的文献求助10
26秒前
FashionBoy应助xiaomaxia采纳,获得10
27秒前
善学以致用应助ponytail采纳,获得10
28秒前
xie老板完成签到,获得积分10
28秒前
不配.应助zhu采纳,获得10
28秒前
liu完成签到,获得积分10
32秒前
LLLLLLLL发布了新的文献求助10
36秒前
小叶子完成签到 ,获得积分10
37秒前
41秒前
pluto应助科研通管家采纳,获得10
41秒前
41秒前
高分求助中
Sustainability in Tides Chemistry 2800
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Very-high-order BVD Schemes Using β-variable THINC Method 568
Chen Hansheng: China’s Last Romantic Revolutionary 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3138556
求助须知:如何正确求助?哪些是违规求助? 2789483
关于积分的说明 7791467
捐赠科研通 2445886
什么是DOI,文献DOI怎么找? 1300693
科研通“疑难数据库(出版商)”最低求助积分说明 626058
版权声明 601079